| FSMAX | OEGAX | FSMAX / OEGAX | |
| Total Expense Ratio | 0.04 | 1.05 | 3% |
| Annual Report Gross Expense Ratio | 0.04 | 1.05 | 3% |
| Fund Existence | 14 years | 25 years | - |
| Gain YTD | 11.598 | 7.921 | 146% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 41.5B | 6.15B | 675% |
| Annual Yield % from dividends | 0.43 | 0.00 | - |
| Returns for 1 year | 6.78 | -1.83 | -371% |
| Returns for 3 years | 53.30 | 39.01 | 137% |
| Returns for 5 years | 44.78 | 5.28 | 848% |
| Returns for 10 years | 108.36 | 75.16 | 144% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SMECX | 9.30 | N/A | N/A |
| Invesco Small Cap Equity C | |||
| FIKCX | 71.07 | N/A | N/A |
| Fidelity Advisor Health Care Z | |||
| LRSRX | 13.47 | -0.01 | -0.07% |
| Lord Abbett Small Cap Value R3 | |||
| VMGIX | 112.79 | -0.33 | -0.29% |
| Vanguard Mid-Cap Growth Index Investor | |||
| ETCEX | 14.12 | -0.06 | -0.42% |
| Eventide Exponential Technologies C | |||